A catalog of dermatology utilities: A measure of the burden of skin diseases

Journal of Investigative Dermatology Symposium Proceedings

Volumn 9, Issue 2, 2004, Pages 160-168

  Chen, Suephy C ^a,b,h   Bayoumi, Ahmed M ^c,d   Soon, Seaver L ^a   Aftergut, Kent ^e   Cruz, Ponciano ^e   Sexton, Shenara A ^a   McCall, Calvin O ^a   Goldstein, Mary K ^f,g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h 5001 Woodruff Memorial Building ^*  (United States)

Author keywords

Cost effectiveness analysis; Quality of life; Utility theory

Indexed keywords

ADULT; ALOPECIA; ANALYTIC METHOD; ARTICLE; BLISTER; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DERMATOLOGY; DERMATOLOGY UTILITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTICENTER STUDY; OUTCOMES RESEARCH; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SKIN DISEASE; TIME; UNITED STATES; URTICARIA;

EID: 1842607638     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1087-0024.2003.09112.x     Document Type: Article

References (28)

1. Bayoumi AM, Redelmeier DA: Economic methods for measuring the quality of life associated with HIV infection. Qual Life Res 8:471-480, 1999
2. Bennett K, Torrance G, Tugwell P: Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis. Control Clin Trials 12:118S-128S, 1991
3. Blumenschein K, Johannesson M: An experimental test of question framing in health state utility assessment. Health Policy 45:187-193, 1998
4. Centers for Disease Control and Prevention. Vital Statistics of the United States: 1992 Life Tables. Vol. II, Hyattsville (MD): Centers for Disease Control and Prevention, National Center for Health Statistics, 1996
5. Chen S, Yeung J, Chren MM: Scalpdex: Quality of life survey for scalp dermatoses. Arch Dermatol 138:803-807, 2002
6. Chren MM, Lasek R, Flocke SA, Zyzanski SJ: Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133:1433-1440, 1997
7. Dolan P, Gudex C, Kind P, Williams A: Valuing health states: A comparison of methods. J Health Econ 15:209-231, 1996
8. Drummond M, O'Brien B, Stoddart GL, Torrance G: Methods for the Economic Evaluation of Health Care Programmes. Toronto: Oxford Medical Publishers, 1998
9. Feeny D, Torrance G: Incorporating utility-based quality-of-life assessment measures in clinical trials: two examples. Med Care 27:S190, 1989
10. Gage BF, Cardinalli AB, Owens DK: The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 156:1829-1836, 1995
11. Gold MR, Siegel RG, Weinstein MC (eds): Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996
12. Goldstein M, Tsevat J: Applying Utility Assessment at the "Bedside." In: Chapman GB, Sonnenberg FA (eds). Decision Making in Health Care: Theory, Psychology, and Applications. Cambridge: Cambridge University Press, 2000; p 313-313
13. Grann VR, Panageas KS, Whang W, Antman KH, Neugut AI: Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 16:979-985, 1999
14. Harris RA, Nease RF: The importance of patient preferences for comorbidities in cost-effectiveness analyses. J Health Econ 16:113-119, 1997
15. Hornberger JC, Redelmeier DA, Petersen J: Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 45:505-512, 1992
16. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS: Screening for prostate cancer: a decision analytic view. JAMA 272: 773-780, 1994
17. Laupacis A, Bourne R, Rorabeck C, et al: The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 75:1619-1626, 1993
18. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M: Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 141:1067-1075, 1999
19. McDowell I, Newell C: Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press, 1996
20. Nease RF Jr, Kneeland T, O'Connor GT, et al: Variations in patient utilities of outcomes of the management of chronic stable angina: Implications tor clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA 273:1185, 1995
21. Sanders G, Owens D, et al: A computer-based interview to identify HIV risk behaviors and to assess patient preferences for HIV-related health states. In: Proceedings of the Eighteenth Annual Symposium on Computer Applications in Medical Care, Washington, DC, Philadelphia: Hanley and Belfus, 1994
22. SAS Institute: SAS System. Cary. (NC). SAS Institute, Inc, 1989-96
23. Stalmeier PF, Goldstein MK, Holmes AM, et al: What should be reported in a methods section on utility assessment? Med Decis Making 21:200-207, 2001
24. Tengs TO, Wallace A: One thousand health-related quality-of-life estimates. Med Care 38:583-637, 2000
25. Tolley G, Kenkel D, Fabian R (eds): Valuing Health for Policy: An Economic Approach. Chicago: The University of Chicago Press, 1994
26. Tsevat J, Solzan JG, Kuntz KM, Ragland J, Currier JS, Sell RL, Weinstein MC: Health values of patients infected with human immunodeficiency virus. Med Care 34:44-57, 1996
27. Updike J: At War with My Skin from the Journal of a Leper. New Yorker, 1976, p 28-33
28. Zug KA, Littenberg B, Baughman RD, et al: Assessing the preferences of patients with psoriasis. Arch Dermatol 131:561-568, 1995